Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds (Q39398776)

11 September 2017

title

Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds (English)

1 reference

11 September 2017

0 references

1 reference

9

1 reference

11 September 2017

Francesca Magherini

4

0 references

Alessandra Modesti

object named as

Alessandra Modesti

12

0 references

Chiara Gabbiani

object named as

Chiara Gabbiani

5

0 references

Luigi Messori

object named as

Luigi Messori

11

0 references

author name string

Francesca Guidi

1

1 reference

11 September 2017

Ida Landini

2

1 reference

11 September 2017

Michele Puglia

3

1 reference

11 September 2017

Maria Agostina Cinellu

6

1 reference

11 September 2017

Stefania Nobili

7

1 reference

11 September 2017

Tania Fiaschi

8

1 reference

11 September 2017

Enrico Mini

10

1 reference

11 September 2017

publication date

10 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

4

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

307-314

1 reference

11 September 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Development of an ovarian cancer symptom index: possibilities for earlier detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Defective apoptosis underlies chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Mechanisms of cytotoxicity of selected organogold(III) compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Comparative proteomic analysis of colon cancer cells in response to oxaliplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Actin re-distribution in response to hydrogen peroxide in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Oxidants, oxidative stress and the biology of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

The thioredoxin system—From science to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT00083K

21 January 2018

Identifiers

DOI

10.1039/C2MT00083K

1 reference

11 September 2017

1 reference